WELL Health Technologies (TSE:WELL) Stock Falls 13.2% – What’s Next?

WELL Health Technologies Corp. (TSE:WELL) fell 13.2% on Tuesday. The stock traded as low as C$3.68 and last traded at C$3.69. Approximately 5,287,784 shares were traded during mid-day trading, an increase of 297% from the average daily volume of 1,332,669 shares. The stock had previously closed at C$4.25.

Analyst Upgrades and Downgrades

Separately, TD set a C$8.50 price target on shares of WELL Health Technologies and gave the stock a “buy” rating in a research note on Monday, October 5th. Five investment analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of C$7.40.

WELL Health Technologies Stock Performance

The firm has a market capitalization of C$944.44 million, a price-to-earnings ratio of 184.50, a PEG ratio of -1.93 and a beta of 0.51. The company has a debt-to-equity ratio of 113.98, a current ratio of 1.76 and a quick ratio of 1.02. The firm has a 50 day moving average price of C$4.22 and a 200-day moving average price of C$4.18.

WELL Health Technologies (TSE:WELL) last released its earnings results on Monday, November 9th. The company reported C$0.11 EPS for the quarter. WELL Health Technologies had a negative return on equity of 15.34% and a negative net margin of 8.25%. The firm had revenue of C$407.40 million during the quarter. As a group, sell-side analysts expect that WELL Health Technologies Corp. will post 0.30 earnings per share for the current fiscal year.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. (TSX: WELL) is Canada’s largest outpatient healthcare company and a leading provider of technology-enabled healthcare solutions. WELL is building the infrastructure for a healthier Canada, where every patient gets better care, every provider is empowered by AI, and every piece of health data is protected. WELL owns and operates more than 250 clinics in Canada, supporting more than 5 million annual patient visits. Through its subsidiary WELLSTAR, WELL provides electronic medical records, AI-powered clinical tools, patient engagement platforms and IT management services.